12/5/25 20:00 | 12/4/25 | DNTH | Health | Drug | Pharmaceutical Preparations | Savitz Ryan | NY | O | CFO,CBO | M.d | 169 | 8.44 | 0 | 20 | | 0 | D | | | | | | | | | | | | | | |
12/5/25 20:00 | 12/4/25 | DNTH | Health | Drug | Pharmaceutical Preparations | Savitz Ryan | NY | O | CFO,CBO | S.d | -904 | 45.18 | 0 | -20 | -100 | 0 | D | | | | | | | | | | | | | | |
11/14/25 21:00 | 11/13/25 | DNTH | Health | Drug | Pharmaceutical Preparations | Randhawa Simrat | NY | O | EVP,Head | M.dm | 2,998 | 15.25 | 0 | 197 | | 4 | D | | | | | | | | | | | | | | |
11/14/25 21:00 | 11/13/25 | DNTH | Health | Drug | Pharmaceutical Preparations | Randhawa Simrat | NY | O | EVP,Head | S.dm | -7,380 | 37.55 | 0 | -197 | -98 | 4 | D | | | | | | | | | | | | | | |
9/11/25 17:20 | 9/9/25 | DNTH | Health | Drug | Pharmaceutical Preparations | Savitz Ryan | NY | O | CFO,CBO | M.d | 169 | 8.44 | 0 | 20 | | 0 | D | | | | | | | | | | | | | | |
9/11/25 17:20 | 9/9/25 | DNTH | Health | Drug | Pharmaceutical Preparations | Savitz Ryan | NY | O | CFO,CBO | S.d | -700 | 35.00 | 0 | -20 | -100 | 0 | D | | | | | | | | | | | | | | |
10/3/23 16:00 | 9/29/23 | DNTH | Health | Drug | Pharmaceutical Preparations | Fairmount Funds Management LLC | PA | DT | | P | 336 | 13.63 | 0 | 25 | 1 | 1,929 | I | | | | | | | | | | | | | | |
9/28/23 17:09 | 9/26/23 | DNTH | Health | Drug | Pharmaceutical Preparations | Fairmount Funds Management LLC | PA | DT | | P | 395 | 13.15 | 0 | 30 | 2 | 1,904 | I | | | | | | | | | | | | | | |
9/25/23 16:15 | 9/21/23 | DNTH | Health | Drug | Pharmaceutical Preparations | Randhawa Simrat | NY | O | Chief Me | P.m | 53 | 13.20 | 0 | 4 | New | 4 | D | | | | | | | | | | | | | | |
9/21/23 16:23 | 9/19/23 | DNTH | Health | Drug | Pharmaceutical Preparations | Fairmount Funds Management LLC | PA | DT | | P | 396 | 13.20 | 0 | 30 | 2 | 1,874 | I | | | | | | | | | | | | | | |
9/13/23 21:17 | 9/12/23 | DNTH | Health | Drug | Pharmaceutical Preparations | Fairmount Funds Management LLC | PA | DT | | P.dm | 272 | 11.20 | 0 | 24 | 1 | 1,844 | I | | | | | | | | | | | | | | |